For the Inventor, By the Inventor

Enter inventor name

Gaithersburg, MD, United States of America

Bimal Chakrabarti

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Genvec, Inc., Genvex, Inc.. Active years: 2008-2015.

USPTO Granted Patents = 7

% Patents Active = 28.6

CIPO Patents = 1

EPO Patents = 4

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 99(Granted Patents)

Location History:

Gaithersburg, MD (US) (2008 - 2011)
San Diego, CA (US) (2012 - 2013)
Gaithersberg, MD (US) (2012 - 2015)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

where one patent can have more than one assignee

Years Active: 2008-2015

Loading Chart...

Loading Chart...

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9012618 - Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures (2015-04-21),

2. 8454972 - Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen (2013-06-04),

3. 8323961 - HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV (2012-12-04),

4. 8101739 - Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector (2012-01-24),

5. 7947822 - HIV vaccines based on Env of multiple clades of HIV (2011-05-24),

6. 7666427 - HIV vaccines based on Env of multiple clades of HIV (2010-02-23),

7. 7470430 - Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization (2008-12-30),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

Loading…